BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25909290)

  • 21. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
    Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
    Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracranial ependymomas: molecular insights and translation to treatment.
    Lester A; McDonald KL
    Brain Pathol; 2020 Jan; 30(1):3-12. PubMed ID: 31433520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
    Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
    Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Merlin expression in pediatric anaplastic ependymomas real time PCR study.
    Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Sardi I; Genitori L; Taddei GL
    Fetal Pediatr Pathol; 2010; 29(4):245-54. PubMed ID: 20594149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.
    Milde T; Pfister S; Korshunov A; Deubzer HE; Oehme I; Ernst A; Starzinski-Powitz A; Seitz A; Lichter P; von Deimling A; Witt O
    Genes Chromosomes Cancer; 2009 Mar; 48(3):229-38. PubMed ID: 19025795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches.
    Lee CH; Chung CK; Kim CH
    Eur Spine J; 2016 Dec; 25(12):3942-3951. PubMed ID: 27637901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYCN amplification drives an aggressive form of spinal ependymoma.
    Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
    Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis.
    Peyre M; Commo F; Dantas-Barbosa C; Andreiuolo F; Puget S; Lacroix L; Drusch F; Scott V; Varlet P; Mauguen A; Dessen P; Lazar V; Vassal G; Grill J
    PLoS One; 2010 Sep; 5(9):e12932. PubMed ID: 20885975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prognostic gene expression signature in infratentorial ependymoma.
    Wani K; Armstrong TS; Vera-Bolanos E; Raghunathan A; Ellison D; Gilbertson R; Vaillant B; Goldman S; Packer RJ; Fouladi M; Pollack I; Mikkelsen T; Prados M; Omuro A; Soffietti R; Ledoux A; Wilson C; Long L; Gilbert MR; Aldape K;
    Acta Neuropathol; 2012 May; 123(5):727-38. PubMed ID: 22322993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
    Li Y; Sahni N; Yi S
    Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastasizing anaplastic ependymoma in an adult. Chromosomal imbalances, metabolic and gene expression profiles.
    Lopez-Gines C; Gil-Benso R; Faus C; Monleon D; Mata M; Morales JM; Cigudosa JC; Gonzalez-Darder J; Celda B; Cerda-Nicolas M
    Histopathology; 2009 Mar; 54(4):500-4. PubMed ID: 19309408
    [No Abstract]   [Full Text] [Related]  

  • 33. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.
    Michalowski MB; de Fraipont F; Michelland S; Entz-Werle N; Grill J; Pasquier B; Favrot MC; Plantaz D
    Cancer Genet Cytogenet; 2006 Apr; 166(1):74-81. PubMed ID: 16616114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shared molecular targets in pediatric gliomas and ependymomas.
    Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
    Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosome aberrations in four ependymomas.
    Sawyer JR; Sammartino G; Husain M; Boop FA; Chadduck WM
    Cancer Genet Cytogenet; 1994 Jun; 74(2):132-8. PubMed ID: 8019957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.
    Yi W; Haapasalo H; Holmlund C; Järvelä S; Raheem O; Bergenheim AT; Hedman H; Henriksson R
    Clin Neuropathol; 2009; 28(1):21-7. PubMed ID: 19216216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.
    Liu Y; Hu H; Zhang C; Wang H; Zhang W; Wang Z; Li M; Zhang W; Zhou D; Jiang T
    Oncotarget; 2015 Nov; 6(35):38257-69. PubMed ID: 26468983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A family with spinal anaplastic ependymoma: evidence of loss of chromosome 22q in tumor.
    Yokota T; Tachizawa T; Fukino K; Teramoto A; Kouno J; Matsumoto K; Emi M
    J Hum Genet; 2003; 48(11):598-602. PubMed ID: 14566482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.
    Rajaram V; Gutmann DH; Prasad SK; Mansur DB; Perry A
    Mod Pathol; 2005 Jul; 18(7):991-7. PubMed ID: 15731777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.
    Rousseau-Merck M; Versteege I; Zattara-Cannoni H; Figarella D; Lena G; Aurias A; Vagner-Capodano AM
    Cancer Genet Cytogenet; 2000 Sep; 121(2):223-7. PubMed ID: 11063814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.